
Nicox S.A.
NICXF
|
PNK
|
0 Sledující
Company Quality
Profitability Score
17/100
Solvency Score
33/100
Dividends
Dividends data currently unavailable.Earnings
7/16/2025
in 37 days
$1.5M
Revenue est.
-
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sektor
Biotechnology
Průmysl
Dr. Gavin M. Spencer
CEO
28
Zaměstnanci
Biot
Centrála
FR
Země
Key Metrics TTM
Valuation
Market cap.
$15MEnterprise Value
$22MPrice to Earnings
-0.49Price to Sales
1.94Price to Book
3.20Price to Cash Flow
-0.66Profitability
Return on Assets
-91.68%Return on Equity
-180.37%Return on Invested Capital
-46.51%Gross Margin
85.88%Operating Margin
-125.38%Net Margin
-284.90%Liquidity
Quick Ratio
6.63Current Ratio
6.63Cash Ratio
2.95Inventory Turnover
0.00Asset Turnover
0.32Total Liabilities
$28MSolvency
Debt to Assets
0.73Debt to Equity
N/AInterest Coverage
-6.33Equity Ratio
0.40Long-term Debt to Cap.
0.81Altman Z-Score
-14.76Performance
Performance data currently unavailable.
Earnings Waterfall
Debt level and coverage
Debt level and coverage data currently unavailable.
Earnings
Feed
There are no posts to show right now.